Literature DB >> 30794285

Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study.

G Pineton de Chambrun1, B Pariente2, P Seksik3, R Altwegg1, L Vuitton4, C Stefasnescu5, S Nancey6, A Aubourg7, M Serrero8, L Peyrin-Biroulet9, J Filippi10, S Viennot11, V Abitbol12, M Boualit13, A Boureille14, J Moreau15, A Buisson16, X Roblin17, M Nachury2, M Zappa18, J Lambert19, Y Bouhnik5.   

Abstract

doi:10.1093/ecco-jcc/jjy222 Abstract P528 from the 'Poster presentations' section of the main abstract book has been withdrawn and re-inserted as DOP63 in the 'Late-breaking abstracts' section.
© The Author(s) 2019. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID： 30794285     DOI： 10.1093/ecco-jcc/jjz045

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


  2 in total

1.  Vedolizumab in Crohn's disease with rectal fistulas and presacral abscess: A case report.

Authors:  Heng Yeh; Chia-Jung Kuo; Ren-Chin Wu; Chien-Ming Chen; Wen-Sy Tsai; Ming-Yao Su; Cheng-Tang Chiu; Puo-Hsien Le
Journal:  World J Gastroenterol       Date:  2021-02-07       Impact factor: 5.742

Review 2.  Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives.

Authors:  Pusen Wang; Zhongyi Jiang; Chunguang Wang; Xueni Liu; Hao Li; Dingyin Xu; Lin Zhong
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.